Welcome to our dedicated page for Sociedad Quimica y Minera SEC filings (Ticker: SQM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Sociedad Química y Minera de Chile S.A. (SQM) provides access to the company’s regulatory reports as a foreign private issuer. SQM files annual reports on Form 20-F and interim reports on Form 6-K under the Securities Exchange Act of 1934, presenting consolidated financial statements, segment information and descriptions of its operations in lithium and derivatives, Specialty Plant Nutrition, iodine and derivatives, potassium and other businesses.
Through its Form 6-K submissions, SQM furnishes earnings releases for periods such as the three, six, nine and twelve months ended on various dates, along with translated consolidated interim financial statements. These documents detail revenues, net income or loss, gross profit, and segment performance, as well as notes on accounting policies, joint ventures, related-party transactions and risk management. They also include disclosures on capital expenditure plans, bond issuances in the Chilean market and the financial effects of partnerships such as the association with Codelco for the Salar de Atacama.
Some 6-K filings address specific corporate events, including the completion of the association agreement with Codelco, approval by the State Administration for Market Regulation of the People’s Republic of China, and the issuance of local hybrid bonds. Others provide unaudited interim financial statements and reconciliations that clarify tax treatment and other accounting matters.
On Stock Titan, these filings are paired with AI-powered summaries that highlight key figures, segment trends and notable disclosures from each document. Users can quickly see how SQM reports lithium volumes and pricing, iodine and plant nutrition performance, capital structure changes and the impact of joint ventures, while still having direct access to the full text of each Form 20-F and Form 6-K filed with the SEC.
Sociedad Química y Minera de Chile (SQM) completed the placement of its local Series S hybrid bonds in the Chilean general securities market, issuing UF 10,000,000 (approximately US$430 million) as part of a 35-year bond program registered with the CMF under No. 1239.
The Series S Bonds mature on February 15, 2058, carry a fixed annual interest rate of 4% on principal expressed in UF starting November 15, 2025, and were placed at an effective rate of 3.84%, including a 1.52% spread over a Central Bank of Chile UF-denominated bond of equivalent term. SQM plans to use the proceeds for general corporate purposes and to refinance existing debt.
Sociedad Química y Minera de Chile (SQM) has issued Series S local hybrid bonds in Chile for a total of 10,000,000 UF, described as approximately US$430 million. These bonds are part of a 35-year bond program registered with the Chilean Commission for the Financial Market.
The Series S Bonds mature on February 15, 2058 and carry a fixed annual interest rate of 4% on principal expressed in UF, starting November 15, 2025. The effective placement rate was 3.84%, which reflects a 1.52% spread over a UF-denominated Central Bank of Chile bond of equivalent term.
SQM states that the proceeds from this issuance will be used for general corporate purposes and to refinance existing debt, which means the funds can both support ongoing operations and replace older borrowing.
Sociedad Química y Minera de Chile (SQM) reported net income of US$404.4 million (US$1.42 per share) for the nine months ended September 30, 2025, reversing a net loss of US$(524.5) million (US$(1.84) per share) a year earlier. Revenues for the period were US$3,252.4 million, down 5.9% year-on-year, while gross profit declined to US$904.1 million, or 27.8% of revenues.
In the third quarter, net income rose 35.8% to US$178.4 million, with revenues up 8.9% to US$1,173.0 million and gross profit up 23.1% to US$345.8 million. Lithium and derivatives drove results, with Q3 segment revenues up 21.4% to US$603.7 million on record sales volumes and a modest price recovery from Salar de Atacama operations.
Iodine and derivatives posted higher revenues supported by strong prices, and specialty plant nutrition delivered modest volume and revenue growth. Potassium revenues fell sharply as SQM deliberately reduced potash output to favor lithium in the Salar de Atacama. The company updated its 2025–2027 capex plan to US$2.7 billion and highlighted Chinese antitrust approval for its Atacama partnership with Codelco.
Sociedad Química y Minera de Chile (SQM) announced that China’s State Administration for Market Regulation (SAMR) approved the public‑private partnership between SQM and Codelco to develop extractive, productive, and commercial activities related to CORFO’s mining properties in the Salar de Atacama.
SAMR’s approval is conditioned on commitments covering: (i) safeguards against exchanging sensitive information with other lithium market participants; (ii) corporate governance practices; and (iii) supplying minimum quantities of finished lithium carbonate to Chinese customers on FRAND terms at prices that cannot exceed those set under the commitment. SQM stated these commitments are consistent with its established practices in China and estimates that, had they applied from 2023 to now, its results would not have changed substantially. An English translation of SAMR’s approval decision and the commitment will be made available to shareholders.
Sociedad Qu edmica y Minera de Chile S.A. (SQM) presents consolidated interim financial statements for the six months ended June 30, 2025 and comparative periods. Total assets were ThUS$11,524,036 with total equity of ThUS$5,393,685 and total liabilities of ThUS$6,130,351. For January to June 2025 revenue was ThUS$2,079,307 and gross profit ThUS$558,264. SQM reported net income of ThUS$227,720 for the period, a reversal from a net loss of ThUS$653,860 in the prior-year period, driven after income tax expense of ThUS$130,958 in 2025 versus a large tax expense in 2024. Cash and cash equivalents were ThUS$1,565,586 at June 30, 2025 and current inventories were ThUS$1,851,147. The Joint Venture Agreement with Codelco is disclosed but not effective as of the reporting date and, if conditions are met in 2025, would reclassify certain amounts to non-controlling interests and create a dividend payable to Codelco calculated by an agreed methodology.
Sociedad Quimica y Minera de Chile S.A. (SQM) reports select metrics for mid-2025. The company indicated it files annual reports on Form 20-F and provided an address for its principal executive office in Santiago, Chile. The Lithium and Derivatives segment reported an adjusted gross margin of 21% for Q2 2025. In Specialty Plant Nutrition (SPN), revenue for the six months ended June 30, 2025 was US$472.6 million, slightly above US$468.2 million for the same period in 2024. SPN revenue for Q2 2025 was US$260.3 million, essentially flat versus US$260.5 million in Q2 2024.